Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat, Joel S. Parker, Olga A. Karginova et al. · Breast Cancer Research · 2010
INTRODUCTION: In breast cancer, gene expression analyses have defined five tumor subtypes (luminal A, luminal B, HER2-enriched, basal-like and claudin-low), each of which has unique biologic and prognostic features. Here, we comprehensively characterize the recently identified claudin-low tumor subtype. METHODS: The clinical, pathological and biological features of claudin-low tumors were compared to the other tumor subtypes using an updated human tumor database and multiple independent data sets. These main features of claudin-low tumors were also evaluated in a panel of breast cancer cell lines and genetically engineered mouse models. RESULTS: Claudin-low tumors are characterized by the low to absent expression of luminal differentiation markers, high enrichment for epithelial-to-mesenchymal transition markers, immune response genes and cancer stem cell-like features. Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation. They also have a response rate to standard preoperative chemotherapy that is intermediate between that of basal-like and luminal tumors. Interestingly, we show that a group of highly utilized breast cancer cell lines, and several genetically engineered mouse models, express the claudin-low phenotype. Finally, we confirm that a prognostically relevant differentiation hierarchy exists across all breast cancers in which the claudin-low subtype most closely resembles the mammary epithelial stem cell. CONCLUSIONS: These results should help to improve our understanding of the biologic heterogeneity of breast cancer and provide tools for the further evaluation of the unique biology of claudin-low tumors and cell lines.
Cited by 2,167 works. doi:10.1186/bcr2635 Open-access PDF
Authors
- Aleix Prat
- Joel S. Parker
- Olga A. Karginova
- Cheng Fan
- Chad Livasy
- Jason I. Herschkowitz
- Xiaping He
- Charles M. Perou
References
- Cluster analysis and display of genome-wide expression patterns
- Molecular portraits of human breast tumours
- Gene expression profiling predicts clinical outcome of breast cancer
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
- A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
- Prospective identification of tumorigenic breast cancer cells
- DAVID: Database for Annotation, Visualization, and Integrated Discovery
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
- Systematic variation in gene expression patterns in human cancer cell lines